Market Overview: 

Report Attribute
Base Year
Forecast Years 2023-2033
Historical Years
Market Size in 2022
US$ 1,591.8 Million
Market Forecast in 2033
US$ 3,122.0 Million
Market Growth Rate (2023-2033)

The  abdominal aortic aneurysm market size reached a value of US$ 1,591.8 Million in 2022 and expects to reach US$ 3,122.0 Million by 2033, exhibiting a growth rate (CAGR) of 6.32% during 2023-2033.

The abdominal aortic aneurysm market report offers a comprehensive analysis of the market in the United States, EU5 (including Germany, Spain, Italy, France, and the United Kingdom), and Japan. It covers aspects such as treatment methods, drugs available in the market, drugs in development, the market share of various therapies, and the market's performance in the seven major regions. Additionally, the report evaluates the performance of leading companies and their pharmaceutical products. Current and projected patient numbers across these key markets are also detailed in the report. This study is essential for manufacturers, investors, business planners, researchers, consultants, and anyone interested or involved in the abdominal aortic aneurysm market.

Request for a Free Sample of this Report:

Abdominal Aortic Aneurysm Market Trends:

An abdominal aortic aneurysm (AAA) refers to a condition where a section of the aorta becomes enlarged and weakened, causing it to bulge outward. It is most commonly found in the lower part of the aorta in the abdomen and can grow over time, increasing the risk of rupture and life-threatening bleeding. In the fields of healthcare and medicine, the abdominal aortic aneurysm market has developed tremendously. This increase is caused by various factors, some of which may be clearly defined as key market drivers. First and foremost, the growing older population is an evident driver. As the age demographics tilt towards the older spectrum, the prevalence of abdominal aortic aneurysms naturally sees an upward trend. Moreover, with age often comes a multitude of other health complications that can be potential risk factors for AAA, such as hypertension, atherosclerosis, and high cholesterol.

Additionally, advancements in diagnostic methodologies and imaging technologies have played a pivotal role. In fact, earlier detection and better visualization techniques have led to a greater number of diagnosed abdominal aortic aneurysm cases, thereby expanding the market. These technological advancements, coupled with the widespread availability of modern medical facilities in developing regions, have created an informed patient base seeking timely interventions. Furthermore, public campaigns and educational programs on abdominal aortic aneurysms have mushroomed in recent years. Consequently, these initiatives have not only enhanced general awareness but have also prompted individuals to seek medical consultations and screenings at earlier stages. On another note, the escalating research and development investments in abdominal aortic aneurysm therapeutics and endovascular repair devices are another significant market driver. Companies are investing heavily in research to develop novel, minimally invasive techniques and more efficient grafts, stents, and endografts. Such innovations, when introduced to the market, naturally increase the demand and acceptance of abdominal aortic aneurysm treatments.

Countries Covered:

• United States
• Germany
• France
• United Kingdom
• Italy
• Spain
• Japan

Analysis Covered Across Each Country:

• Historical, current, and future epidemiology scenario
• Historical, current, and future performance of the abdominal aortic aneurysm market
• Historical, current, and future performance of various therapeutic categories in the market
• Sales of various drugs across the abdominal aortic aneurysm market
• Reimbursement scenario in the market
• In-market and pipeline drugs

This report also provides a detailed analysis of the current abdominal aortic aneurysm marketed drugs and late-stage pipeline drugs.

In-Market Drugs:

• Drug Overview
• Mechanism of Action
• Regulatory Status
• Clinical Trial Results
• Drug Uptake and Market Performance

Late-Stage Pipeline Drugs:

• Drug overview
• Mechanism of action
• Regulatory status
• Clinical trial results
• Drug uptake and market performance

Competitive Landscape :

The competitive landscape of the abdominal aortic aneurysm market has been studied in the report with the detailed profiles of the key players operating in the market.

Ask Analyst for Customization and Explore Full Report With TOC & List of Figures:

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Media Contact:

Company Name: IMARC Group

Contact Person: Elena Anderson

Email: [email protected]

Phone: +1-631-791-1145

Address: 134 N 4th St

City: Brooklyn

State: NY

Country: United States